TITLE

The Risk of Acute Major Upper Gastrointestinal Bleeding Among Users of Aspirin and Ibuprofen at Various Levels of Alcohol Consumption

AUTHOR(S)
Kaufman, David W.; Kelly, Judith Parsells; Wiholm, Bengt-Erik; Laszlo, András; Sheehan, Jane E.; Koff, Raymond S.; Shapiro, Samuel
PUB. DATE
November 1999
SOURCE
American Journal of Gastroenterology;Nov1999, Vol. 94 Issue 11, p3189
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: Major upper gastrointestinal bleeding (UGIB) is the most important adverse effect of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs). Alcoholic beverages also precipitate UGIB. This analysis was conducted to evaluate whether the deleterious effects of NSAIDs are further increased among drinkers. METHODS: An interview-based, case-control study was conducted in the U.S. and Sweden; 1224 patients hospitalized with acute major UGIB due to newly occurring peptic ulcer or gastritis were compared to 2945 neighbor controls. RESULTS: Compared with those who drank less than one drink/wk, the relative risk of acute UGIB increased with increasing alcohol consumption, rising to 2.8 among those who drank ≥21 drinks/wk. Among current drinkers, the relative risk of acute UGIB due to the use of aspirin was raised at all levels of alcohol consumption; the estimate for aspirin taken at least every other day (regular use) at doses of >325 mg among all current drinkers combined was 7.0; for regular use at lower doses, the corresponding estimate was 2.8, and for any occasional use, it was 2.4. All estimates were statistically significant. Data for ibuprofen were more limited, but the relative risk estimates did not appear to vary consistently with level of alcohol consumption. For regular use (all doses combined), the estimate among all drinkers combined was significantly elevated, at 2.7; occasional ibuprofen use was not associated with UGIB (1.2). There were insufficient data to evaluate other NSAIDs according to alcohol consumption. CONCLUSIONS: The findings suggest that acute UGIB is similarly associated with the use of the two most common nonprescription NSAIDs, aspirin and ibuprofen, at all levels of alcohol consumption. As heavy alcohol intake independently increases the risk, the incidence of UGIB is highest among persons who are both heavy drinkers and users of aspirin or ibuprofen.
ACCESSION #
17633113

 

Related Articles

  • NSAIDs and Alcohol: Never the Twain Shall Mix? Pfau, Patrick R.; Lichtenstein, Gary R. // American Journal of Gastroenterology;Nov1999, Vol. 94 Issue 11, p3098 

    Offers a look at the interaction of alcohol and aspirin or nonsteroidal anti-inflammatory drugs (NSAID) in upper gastrointestinal bleeding (UGIB). Pathophysiology of NSAID and aspirin-induced ulceration and mucosal injury; Effect of alcohol on the risk of UGIB among NSAID users; Reference to a...

  • Risk Factors for Gastrointestinal Complications in Aspirin Users: Review of Clinical and Experimental Data.  // Digestive Diseases & Sciences;Oct2008, Vol. 53 Issue 10, p2604 

    Abstract  This paper reviews recent clinical evidence that suggests that aspirin prophylaxis against cardiac and cerebral vascular ischemia is associated with significant gastrointestinal complications. The clinical and experimental evidence to confirm the role of risk factors of...

  • Reduce Your Risk of a Stomach Ulcer.  // Arthritis Today;Nov/Dec2008, Vol. 22 Issue 6, p59 

    The article presents tips on how patients can reduce the risk of a stomach ulcer while taking non-steroidal anti-inflammatory drugs. Patients should take the lowest dosage possible to get relief. NSAIDs should be taken at mealtime, since food stimulates the production of protective mucus in the...

  • To Drink or Not to Drink? Gotterman, Nancy // Arthritis Today;Sep/Oct2008, Vol. 22 Issue 5, p39 

    The article discusses a study which suggests that drinking three or more alcoholic beverages per week could reduce by half the risk of developing rheumatoid arthritis. Researchers also cite that drinking alcohol and taking nonsteroidal anti-inflammatory drugs such as naproxen increases one's...

  • Pancreatitis.  // Current Medical Literature: Gastroenterology;2009, Vol. 28 Issue 1, p20 

    This section presents abstracts of two studies related to pancreatitis including "A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis" and "Incidence and case fatality for acute pancreatitis in England: geographical variation, social deprivation, alcohol consumption and...

  • Gastroduodenal Complications of Chronic NSAID Therapy. Graham, David Y.; Smith, J. Lacey // American Journal of Gastroenterology;Oct1988, Vol. 83 Issue 10, p1081 

    The fact that nonsteroidal anti-inflammatory drugs (NSAIDs) damage the gastroduodenal mucosa is no longer contested. Endoscopic studies in normal volunteers after NSAID administration have failed to predict which NSAIDs would be safest when administered chronically. NSAID use has been associated...

  • Značaj Helicobacter pylori infekcije i nesteroidnih antiinflamatornih lekova kod bolesnika sa krvarenjem iz gornjeg dela gastrointestinalnog trakta. Golubović, Gradimir; Tomašević, Ratko; Radojević, Biljana; Pavlović, Aleksandar; Dugalić, Predrag // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Jul2007, Vol. 64 Issue 7, p445 

    Background/Aim. Helicobacter pylori (H. pylori) infection and nonsteroidal anti-inflammatory drugs (NSAIDs) use are considered to be the most important risk factors having influence on the onset of bleeding gastroduodenal lesions. Whether there is an interaction between H. pylori infection and...

  • Risk of Upper Gastrointestinal Bleeding Associated With Use of Low-Dose Aspirin. Sørensen, Henrik Toft; Mellemkjær, Lene; Blot, William J.; Nielsen, Gunnar Lauge; Steffensen, Flemming Hald; McLaughlin, Joseph K.; Olsen, Jørgen H. // American Journal of Gastroenterology;Sep2000, Vol. 95 Issue 9, p2218 

    OBJECTIVE: Aspirin products are known to cause irritation and injury to the gastric mucosa. We examined the risk of hospitalization for upper gastrointestinal bleeding with use of low-dose aspirin. METHODS: This was a cohort study based on record linkage between a population-based prescription...

  • Rapid Protection of the Gastroduodenal Mucosa Against Aspirin-induced Damage by Rabeprazole. Robinson, Malcolm // Internal Medicine Alert;4/29/2008, Vol. 30 Issue 8, p57 

    The article discusses the effectiveness of rabeprazole in reducing gastroduodenal damages caused by aspirin and other nonsteroidal anti-inflammatory agents (NSAIDs). The study shows that aspirin can cause gastric and duodenal submucosal hemorrhages and erosion but can be prevented by...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics